Does Unicycive Therapeutics (UNCY) pay a dividend?
Yes. Unicycive Therapeutics (UNCY) pays a dividend: $0.16 per share for fiscal 2024, a dividend yield of 4.36% at the latest close.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (0) × 0.40 + Growth (0) × 0.35 + Income (45) × 0.25 = 11
Dividend Safety
Earnings Payout
Not reported
FCF Payout
–
FCF Coverage
–
Dividend Growth
Per Share (FY2024)
$0.16
Growth Streak
–
1Y CAGR
-55.4%
Dividend history
| Fiscal year | Per share | Change |
|---|---|---|
| 2024 | $0.16 | -55.4% |
| 2023 | $0.37 |
All 2 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.
Computed from SEC filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.
Dividend Income
Annual DPS (FY2024)
$0.16
Annual Income / $10K
$436
Payment frequency, ex-dividend and payment dates are not available from SEC filings. Check your broker or the company's investor relations page for the schedule.
Unicycive Therapeutics (UNCY) dividend: yield, safety and growth
Frequently asked
Does Unicycive Therapeutics (UNCY) pay a dividend, and how much?+
Yes, Unicycive Therapeutics pays a regular dividend of about $0.16 per share for fiscal 2024 (a yield of roughly 4.4%). A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.
Is Unicycive Therapeutics's dividend safe?+
Unicycive Therapeutics's dividend looks dependent on payout coverage. Intrinsiqq scores its dividend safety at 0 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.
Has Unicycive Therapeutics grown its dividend?+
Unicycive Therapeutics's dividend history is mixed. Recent dividend growth has been roughly flat. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.
SourceDividend analysis computed from the 10-Q filed 12 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Peers
Pharmaceutical Preparations · Pick stocks to compare with UNCY
Held by ETFs
UNCY is in 3 US ETFs. The largest of them, with UNCY's weight in each:
Spot a number that looks wrong? Check it in UNCY's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing UNCY
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.